Moderna patented genetic sequence found in SARS-CoV-2 three years before pandemic

 

28 February 2022

 

Scientists have discovered in the spike protein of SARS-CoV-2 genetic sequence that was patented by vaccine manufacturer Moderna in 2016 for cancer research purposes.

This snippet of genetic code was found in SARS-CoV-2’s unique furin cleavage site, making it more infectious than ordinary coronavirus.

They claim there is a one-in-three-trillion chance Moderna’s sequence randomly appeared through natural evolution supporting the hypothesis that SARS-CoV-2 indeed originated in a laboratory.

 

fviro-02-834808

 

 

Moderna patent

 

US10702600
error: